-
1
-
-
0033072530
-
Growth factors in inflammatory bowel disease
-
Beck, P. L. & Podolsky, D. K. Growth factors in inflammatory bowel disease. Infl amm. Bowel Dis. 5, 44-60 (1999).
-
(1999)
Infl Amm. Bowel Dis
, vol.5
, pp. 44-60
-
-
Beck, P.L.1
Podolsky, D.K.2
-
2
-
-
0142053206
-
The immunological and genetic basis of inflammatory bowel disease
-
Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. 3, 521-533 (2003).
-
(2003)
Nat. Rev
, vol.3
, pp. 521-533
-
-
Bouma, G.1
Strober, W.2
-
3
-
-
0031781603
-
Inflammatory bowel disease: Etiology and pathogenesis
-
Fiocchi, C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115, 182-205 (1998).
-
(1998)
Gastroenterology
, vol.115
, pp. 182-205
-
-
Fiocchi, C.1
-
4
-
-
0023133547
-
The long-term outcome in Crohn’s disease
-
Harper, P. H. et al. The long-term outcome in Crohn’s disease. Dis. Colon. Rectum 30, 174-179 (1987).
-
(1987)
Dis. Colon. Rectum
, vol.30
, pp. 174-179
-
-
Harper, P.H.1
-
5
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky, D. K. Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429 (2002).
-
(2002)
N. Engl. J. Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
6
-
-
27644453163
-
Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-kappaB decoy oligonucleotides
-
Fichtner-Feigl, S., Fuss, I. J., Preiss, J. C., Strober, W. & Kitani, A. Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-kappaB decoy oligonucleotides. J. Clin. Invest. 115, 3057-3071 (2005).
-
(2005)
J. Clin. Invest
, vol.115
, pp. 3057-3071
-
-
Fichtner-Feigl, S.1
Fuss, I.J.2
Preiss, J.C.3
Strober, W.4
Kitani, A.5
-
7
-
-
0344792632
-
A murine model of chronic inflammation-induced intestinal fi brosis down-regulated by antisense NF-kappa B
-
Lawrance, I. C. et al. A murine model of chronic inflammation-induced intestinal fi brosis down-regulated by antisense NF-kappa B. Gastroenterology 125, 1750-1761 (2003).
-
(2003)
Gastroenterology
, vol.125
, pp. 1750-1761
-
-
Lawrance, I.C.1
-
8
-
-
18244405108
-
IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo
-
Fort, M. M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001).
-
(2001)
Immunity
, vol.15
, pp. 985-995
-
-
Fort, M.M.1
-
9
-
-
0037451128
-
Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response
-
Chiaramonte, M. G. et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197, 687-701 (2003).
-
(2003)
J. Exp. Med
, vol.197
, pp. 687-701
-
-
Chiaramonte, M.G.1
-
10
-
-
30044449492
-
IL-13 signaling through the IL-13alpha(2) receptor is involved in induction of TGF-beta(1) production and fibrosis
-
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K. & Kitani, A. IL-13 signaling through the IL-13alpha(2) receptor is involved in induction of TGF-beta(1) production and fibrosis. Nat. Med. 12, 99-106 (2006).
-
(2006)
Nat. Med
, vol.12
, pp. 99-106
-
-
Fichtner-Feigl, S.1
Strober, W.2
Kawakami, K.3
Puri, R.K.4
Kitani, A.5
-
11
-
-
9144219618
-
IL-13 receptor alpha 2 down-modulates granulomatous infl ammation and prolongs host survival in schistosomiasis
-
Mentink-Kane, M. M. et al. IL-13 receptor alpha 2 down-modulates granulomatous infl ammation and prolongs host survival in schistosomiasis. Proc. Natl. Acad. Sci. USA 101, 586-590 (2004).
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 586-590
-
-
Mentink-Kane, M.M.1
-
12
-
-
12144290869
-
P-selectin suppresses hepatic inflammation and fibrosis in mice by regulating interferon gamma and the IL-13 decoy receptor
-
Wynn, T. A. et al. P-selectin suppresses hepatic inflammation and fibrosis in mice by regulating interferon gamma and the IL-13 decoy receptor. Hepatology 39, 676-687 (2004).
-
(2004)
Hepatology
, vol.39
, pp. 676-687
-
-
Wynn, T.A.1
|